GRB7 is required for triple-negative breast cancer cell invasion and survival.
about
FAM83A confers EGFR-TKI resistance in breast cancer cells and in miceThe fate of chemoresistance in triple negative breast cancer (TNBC)Targeting SH2 domains in breast cancerTargeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cellsGrb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.Molecular profiles of pre- and postoperative breast cancer tumours reveal differentially expressed genes.Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.BreastDefend™ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer.Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules.HER-2 gene amplification in human breast cancer without concurrent HER-2 over-expression.Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist.Validation of analytical breast cancer microarray analysis in medical laboratory.Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells.Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target.Design and testing of bicyclic inhibitors of Grb7--are two cycles better than one?Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer.Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting Peptide.Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
P2860
Q24296333-8439D123-1690-42A8-A3D3-4076B1EEA0DAQ26775232-7C536D22-1FD0-4BB7-B960-2564C82B293FQ27014674-B76A73E9-2C97-422E-B4FC-5A3A2215F42FQ28484496-E9BBB76D-D245-41F2-9EE2-05B203524B3DQ36261762-15388333-89AF-4A49-BC5C-8CADCFB22307Q36443179-7FCD2083-8128-4B64-B22C-47ABE652E3AAQ36603829-6DE18CE8-EAF5-4264-92C2-7081A89D9170Q36642447-719D0816-EC0E-4B0D-A715-C54E333D0718Q36758884-43B314BF-6D5A-45EF-B14B-B45D14CE1524Q37216946-43787C39-4D00-43FD-ADCC-F5AB178E387FQ37606276-43CFF2CF-73DE-4584-AB27-A906BF825F75Q38962113-ACB09D11-DA29-4B20-B5FF-5CA770952F8CQ39112367-88E05BAB-2140-43B3-BF5D-62A5425EC345Q39192269-6BA9938C-6A4A-4847-A08B-DD6E086E0E86Q41771691-1F843049-ED57-4BA2-8105-846494CA4925Q42103874-4F06A249-B43F-4D7D-97C5-784E9649CAC6Q44853520-226949D8-0C32-4E57-85C5-C55BF9FF1B32Q46668930-26C4B3AC-09FA-47E1-89CB-D0466E523F3AQ47117237-32ABB717-5B4F-460F-BEC3-AD2A72D9AEF4Q47612265-F7D167EB-CE21-4D97-9F7A-E7546C226AEC
P2860
GRB7 is required for triple-negative breast cancer cell invasion and survival.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
GRB7 is required for triple-negative breast cancer cell invasion and survival.
@en
GRB7 is required for triple-negative breast cancer cell invasion and survival.
@nl
type
label
GRB7 is required for triple-negative breast cancer cell invasion and survival.
@en
GRB7 is required for triple-negative breast cancer cell invasion and survival.
@nl
prefLabel
GRB7 is required for triple-negative breast cancer cell invasion and survival.
@en
GRB7 is required for triple-negative breast cancer cell invasion and survival.
@nl
P2093
P2860
P1476
GRB7 is required for triple-negative breast cancer cell invasion and survival.
@en
P2093
David N Krag
Joseph A Sparano
Orsi Giricz
Paraic A Kenny
Stephanie C Pero
Verónica Calvo
P2860
P2888
P304
P356
10.1007/S10549-011-1822-6
P407
P577
2011-10-18T00:00:00Z